Products formulators love
We’re committed to investing in the next generation of excipients you need. Our teams work with you to troubleshoot formulations and develop research grade and GMP excipient solutions. Purity is our forte across our multi-compendial, GMP grade materials.
Smart science to improve lives™
Your pharma solutions partner:
- High purity excipients: Optimising the performance of formulations to solve your stability and solubility challenges
- Vaccine adjuvants: Committed to the highest standards, with 80+ years of expertise in adjuvant research and development
- Innovative lipids: Enabling the delivery and stability of nucleic acid-based vaccines, therapeutics and gene editing technology.
We are committed to enabling the next generation of drug delivery systems, so by partnering with Croda Pharma, you are in safe hands.
Expert solutions for different markets:
Human and veterinary pharmaceuticals
Consumer Health
Explore recent blogs:
Lipid Leaders: Söhnke Voss
In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...
Read moreProtein Delivery Leaders: Andrew Bright
In this Protein Delivery Leaders interview, we speak to Andrew Bright, PhD. Keep reading to learn more about breakthroughs in protein delivery and key challenges faced in biologic formulations.
Read moreCroda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards
Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...
Read morePartnership agreement between Croda and AAHI to drive innovation in vaccine development
19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...
Read more